Matches in SemOpenAlex for { <https://semopenalex.org/work/W2625138361> ?p ?o ?g. }
- W2625138361 endingPage "789" @default.
- W2625138361 startingPage "789" @default.
- W2625138361 abstract "Autosomal recessive erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) are rare photodermatoses presenting with variable degrees of painful phototoxicity that markedly affects quality of life. The clinical variability, determinants of severity, and genotype/phenotype correlations of these diseases are not well characterized.To describe the baseline clinical characteristics, genotypes, and determinants of disease severity in a large patient cohort with EPP or XLP.A prospective observational study was conducted among patients with confirmed diagnoses of EPP or XLP from November 1, 2010, to December 6, 2015, at 6 academic medical centers of the Porphyrias Consortium of the National Institutes of Health Rare Diseases Clinical Research Network. Detailed medical histories, including history of phototoxicity and treatment, were collected on standardized case report forms. Patients underwent baseline laboratory testing, total erythrocyte protoporphyrin (ePPIX) testing, and molecular genetic testing. Data were entered into a centralized database.Results of biochemical and genetic tests were explored for association with clinical phenotype in patients with EPP or XLP.Of the 226 patients in the study (113 female and 113 male patients; mean [SD] age, 36.7 [17.0] years), 186 (82.3%) had EPP with a FECH (OMIM 612386) mutation and the common low-expression FECH allele IVS3-48T>C, and only 1 patient had 2 FECH mutations. Twenty-two patients had XLP (9.7%; 10 male and 12 female patients), and 9 patients (4.0%) had elevated ePPIX levels and symptoms consistent with protoporphyria but no detectable mutation in the FECH or ALAS2 (OMIM 301300) gene. Samples of DNA could not be obtained from 8 patients. Patients' mean (SD) age at symptom onset was 4.4 (4.4) years. Anemia (107 [47.3%]), history of liver dysfunction (62 [27.4%]), and gallstones (53 [23.5%]) were commonly reported. Higher ePPIX levels were associated with earlier age of symptom onset (median ePPIX levels for those who developed symptoms before vs after 1 year of age, 1744 vs 1567 µg/dL; P = .02), less sun tolerance (median ePPIX levels for those reporting symptoms before vs after 10 minutes of sun exposure, 2233 vs 1524 µg/dL; P ≤ .001), and increased risk of liver dysfunction (median ePPIX levels for those with liver dysfunction vs normal liver function, 2016 vs 1510 µg/dL; P = .003). Patients with EPP and FECH missense mutations had significantly lower ePPIX levels than those with other mutations (1462 vs 1702 µg/dL; P = .01). Male patients with XLP had significantly higher ePPIX levels, on average, than did patients with EPP (3574 vs 1669 µg/dL; P < .001). Marked clinical variability was seen in female patients with XLP owing to random X-chromosomal inactivation.These data suggest that higher ePPIX levels are a major determinant of disease severity and risk of liver dysfunction in patients with EPP or XLP. These findings provide a framework for clinical monitoring and management of these disorders." @default.
- W2625138361 created "2017-06-23" @default.
- W2625138361 creator A5012434409 @default.
- W2625138361 creator A5016192651 @default.
- W2625138361 creator A5027941722 @default.
- W2625138361 creator A5042981297 @default.
- W2625138361 creator A5047956491 @default.
- W2625138361 creator A5065509707 @default.
- W2625138361 creator A5066255279 @default.
- W2625138361 creator A5071669604 @default.
- W2625138361 creator A5072655119 @default.
- W2625138361 creator A5077581228 @default.
- W2625138361 creator A5087206886 @default.
- W2625138361 creator A5090900773 @default.
- W2625138361 date "2017-08-01" @default.
- W2625138361 modified "2023-10-17" @default.
- W2625138361 title "Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria" @default.
- W2625138361 cites W1504092620 @default.
- W2625138361 cites W152918045 @default.
- W2625138361 cites W1530373511 @default.
- W2625138361 cites W1558413186 @default.
- W2625138361 cites W1560322986 @default.
- W2625138361 cites W1581852181 @default.
- W2625138361 cites W1597195256 @default.
- W2625138361 cites W1695754907 @default.
- W2625138361 cites W1786909161 @default.
- W2625138361 cites W184040730 @default.
- W2625138361 cites W1975436079 @default.
- W2625138361 cites W1989375976 @default.
- W2625138361 cites W1998006032 @default.
- W2625138361 cites W2006573365 @default.
- W2625138361 cites W2013858218 @default.
- W2625138361 cites W2045690727 @default.
- W2625138361 cites W2052425126 @default.
- W2625138361 cites W2072277062 @default.
- W2625138361 cites W2081145159 @default.
- W2625138361 cites W2104185157 @default.
- W2625138361 cites W2107857612 @default.
- W2625138361 cites W2122302303 @default.
- W2625138361 cites W2180660046 @default.
- W2625138361 cites W2307188707 @default.
- W2625138361 cites W2317922304 @default.
- W2625138361 cites W2473350985 @default.
- W2625138361 cites W3189899230 @default.
- W2625138361 cites W4292528167 @default.
- W2625138361 doi "https://doi.org/10.1001/jamadermatol.2017.1557" @default.
- W2625138361 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5710403" @default.
- W2625138361 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28614581" @default.
- W2625138361 hasPublicationYear "2017" @default.
- W2625138361 type Work @default.
- W2625138361 sameAs 2625138361 @default.
- W2625138361 citedByCount "58" @default.
- W2625138361 countsByYear W26251383612018 @default.
- W2625138361 countsByYear W26251383612019 @default.
- W2625138361 countsByYear W26251383612020 @default.
- W2625138361 countsByYear W26251383612021 @default.
- W2625138361 countsByYear W26251383612022 @default.
- W2625138361 countsByYear W26251383612023 @default.
- W2625138361 crossrefType "journal-article" @default.
- W2625138361 hasAuthorship W2625138361A5012434409 @default.
- W2625138361 hasAuthorship W2625138361A5016192651 @default.
- W2625138361 hasAuthorship W2625138361A5027941722 @default.
- W2625138361 hasAuthorship W2625138361A5042981297 @default.
- W2625138361 hasAuthorship W2625138361A5047956491 @default.
- W2625138361 hasAuthorship W2625138361A5065509707 @default.
- W2625138361 hasAuthorship W2625138361A5066255279 @default.
- W2625138361 hasAuthorship W2625138361A5071669604 @default.
- W2625138361 hasAuthorship W2625138361A5072655119 @default.
- W2625138361 hasAuthorship W2625138361A5077581228 @default.
- W2625138361 hasAuthorship W2625138361A5087206886 @default.
- W2625138361 hasAuthorship W2625138361A5090900773 @default.
- W2625138361 hasBestOaLocation W26251383612 @default.
- W2625138361 hasConcept C104317684 @default.
- W2625138361 hasConcept C126322002 @default.
- W2625138361 hasConcept C135763542 @default.
- W2625138361 hasConcept C16005928 @default.
- W2625138361 hasConcept C185592680 @default.
- W2625138361 hasConcept C2777799353 @default.
- W2625138361 hasConcept C2778417259 @default.
- W2625138361 hasConcept C2779480358 @default.
- W2625138361 hasConcept C2780673598 @default.
- W2625138361 hasConcept C54355233 @default.
- W2625138361 hasConcept C71924100 @default.
- W2625138361 hasConcept C75473681 @default.
- W2625138361 hasConcept C86803240 @default.
- W2625138361 hasConcept C90924648 @default.
- W2625138361 hasConceptScore W2625138361C104317684 @default.
- W2625138361 hasConceptScore W2625138361C126322002 @default.
- W2625138361 hasConceptScore W2625138361C135763542 @default.
- W2625138361 hasConceptScore W2625138361C16005928 @default.
- W2625138361 hasConceptScore W2625138361C185592680 @default.
- W2625138361 hasConceptScore W2625138361C2777799353 @default.
- W2625138361 hasConceptScore W2625138361C2778417259 @default.
- W2625138361 hasConceptScore W2625138361C2779480358 @default.
- W2625138361 hasConceptScore W2625138361C2780673598 @default.
- W2625138361 hasConceptScore W2625138361C54355233 @default.
- W2625138361 hasConceptScore W2625138361C71924100 @default.
- W2625138361 hasConceptScore W2625138361C75473681 @default.